Immunomodulatory effects of interferons on human mononuclear cells with special reference to the expression of cell surface antigens.
Hokland
M E
ME
D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D000954:Antigens, Surface / Q000276:immunology*; D002454:Cell Differentiation; D003602:Cytotoxicity, Immunologic; D006649:Histocompatibility Antigens / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007113:Immunity, Innate; D007372:Interferons / Q000502:physiology*; D007694:Killer Cells, Natural / Q000276:immunology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000276:immunology*; D008264:Macrophages / Q000276:immunology; D008285:Major Histocompatibility Complex; D009000:Monocytes / Q000276:immunology*; D011961:Receptors, Fc / Q000276:immunology
D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D006649:Histocompatibility Antigens; D000949:Histocompatibility Antigens Class II; D011961:Receptors, Fc; D007372:Interferons